D, Ö., PS, N., J, A., MH, N., E, M., MLH, M., . . . T, T. (2026). Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial. BMC cancer, 26(1), . https://doi.org/10.1186/s12885-026-15859-w
Chicago Style (17th ed.) CitationD, Özcan, Nielsen PS, Alsner J, Nielsen MH, Maae E, Milo MLH, Overgaard J, Offersen BV, and Tramm T. "Associations Between Tumor Immune Response and Prognosis in Node-negative Breast Cancer Patients in the Randomized DBCG HYPO Trial." BMC Cancer 26, no. 1 (2026). https://doi.org/10.1186/s12885-026-15859-w.
MLA (9th ed.) CitationD, Özcan, et al. "Associations Between Tumor Immune Response and Prognosis in Node-negative Breast Cancer Patients in the Randomized DBCG HYPO Trial." BMC Cancer, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12885-026-15859-w.